CNXC vs VRTX · rev $4.96B vs P/E 30, rev $3.33B
Concentrix Corporation (CNXC) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Concentrix Corporation (CNXC) is a information technology services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CNXC revenue for 2026-05-31 was $4.96B. Net income was $76.9M. Revenue was up 98.5% from 2026-02-28 to 2026-05-31. CNXC currently screens at market cap $1.70B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CNXC currently screens at market cap $1.70B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CNXC and VRTX stock pages for the full models.
Not investment advice.